
Copper & Collagen Peptides
IGF-1 LR3
CโโโHโโโ NโโโOโโโ Sโ (approximate)
Key Research Findings
- Characterisation of the LR3-modified IGF-1 sequence and reduced IGFBP affinity.
- Published cell-culture studies on PI3K/Akt-pathway activation.
- In-vitro mitogenic assays in multiple cell lines.
Overview
IGF-1 LR3 is a recombinant analogue of IGF-1, modified with an N-terminal extension and an Arg-for-Glu substitution at position 3. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro studies as an IGF-1-receptor (IGF1R) ligand active on the PI3K/Akt and MAPK/ERK signalling cascades in cell-culture assays. Not intended for human or veterinary use.
Research Effects
IGF1R Binding
Extensive ResearchCharacterised in receptor-binding assays as a high-affinity ligand of the IGF-1 receptor.
PI3K/Akt Pathway Studies
Extensive ResearchPublished cell-culture studies report activation of the PI3K/Akt signalling cascade.
Mitogenic Cell Assays
Moderate ResearchIn-vitro assays report mitogenic activity in multiple cell lines used as research tools.
Research Purposes Only โ All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Related Peptides
Copper & Collagen Peptides
GHK-Cu
GHK-Cu is a synthetic copper-tripeptide complex (Glycyl-L-Histidyl-L-Lysine bound to Cuยฒโบ). Supplied as a lyophilised powder for in-vitro research use only.
Learn More โ
Copper & Collagen Peptides
Epitalon
Epitalon (Epithalon) is a synthetic tetrapeptide derived from a sequence identified in pineal-gland extracts. Supplied as a lyophilised powder for in-vitro research use only.
Learn More โ
GH Secretagogue Peptides
CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic 29-residue analogue of growth-hormone-releasing hormone (GHRH), without the Drug Affinity Complex linker. Supplied as a lyophilised powder for in-vitro research use only.
Learn More โ
